Assist. Prof. Dr. Xiancai Li | Natural Products Chemistry | Research Excellence Award

Assist. Prof. Dr. Xiancai Li | Natural Products Chemistry | Research Excellence Award

South China Botanical Garden, Chinese Academy of Sciences, China

Assist Prof. Dr. Xiancai Li is a dedicated pharmacological researcher recognized for his strong contributions to plant-based therapeutic discovery, particularly in the antimicrobial and uric-acid-lowering potential of natural products. With extensive experience in molecular biology and phytochemical research, he has developed deep expertise in transcriptomic and metabolomic analysis, enabling him to elucidate complex biochemical pathways and identify novel bioactive compounds. He earned his Bachelor of Science in plant protection, followed by a Ph.D. in science, where he focused on natural product pharmacology and plant-derived mechanisms of disease mitigation. His postdoctoral research at the Institute of Genetics and Developmental Biology further strengthened his proficiency in functional genomics and biological validation techniques, leading to several impactful publications in reputable scientific journals. Currently serving as a Research Associate at the South China Botanical Garden, Chinese Academy of Sciences, he continues to advance innovative pharmacological studies with an emphasis on plant resources for drug discovery. His research interests span antimicrobial resistance, metabolic regulation, phytotherapy, and natural product innovation. Throughout his career, he has been recognized with academic honors and research achievements that highlight his commitment to scientific excellence. Dr. Li remains dedicated to advancing evidence-based natural medicine and contributing to global health solutions.

Profile: Orcid

Featured Publications

Li, X., Yu, W., Yao, L., Liu, F., Li, Y., Xiong, B., Xie, J., & Qiu, S.-X. (2026). “Amelioration effects of Cajanus cajan extracts and the active ingredient pinostrobin on hyperuricemia and related kidney injury.” Food & Function.
https://doi.org/10.1039/D5FO01806D

Li, X., Chen, S., Wu, Y., Liu, F., Jumai, A., Zhu, B., Xiong, B., & Qiu, S.-X. (2026). “γ-mangostin from Garcinia mangostana (L.) exerts antifungal activity against Cryptococcus neoformans by inhibiting ribosome biogenesis.” Journal of Ethnopharmacology, March 2026. https://doi.org/10.1016/j.jep.2025.120986

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Changzhou University | China

Dr. Hongyan Lin is a distinguished researcher and lecturer at the School of Pharmaceutical Sciences, Changzhou University, China, with a strong emphasis on natural product chemistry and molecular pharmacology. She completed her Bachelor’s degree in Bioengineering at Changzhou University, followed by an Integrated Master-PhD in Biology at Nanjing University, where she specialized in the biological mechanisms of traditional medicine. Dr. Lin further expanded her expertise as a Postdoctoral Fellow and Research Associate at the School of Life Sciences, Nanjing University, contributing significantly to molecular pharmacology and natural product research. Her research interests focus on the chemical structural modification of natural products for anticancer applications, the role of traditional Chinese medicine in regulating intestinal microbiota to prevent colitis-associated cancer, and the isolation, structural identification, and biological activity of bioactive compounds from traditional herbs. Dr. Lin has been recognized for her scientific contributions through research grants and academic publications in high-impact journals. Her work supports the evolution of natural product-based therapeutics and offers promising directions for cancer prevention and treatment. In her role as a lecturer and researcher, she continues to inspire the next generation of pharmaceutical scientists through her dedication and innovation.

Profiles: Scopus | Orcid

Featured Publications

Lin, H., Ai, D., Liu, Q., Wang, X., Gao, J., Chen, Q., Ruan, L., Tao, Y., Gao, J., & Wang, L. (2023). Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products, Published online July 28, 2023.

Lin, H., Zhou, Z., Ma, X., Chen, Q., Han, H., Wang, X., Qi, J., & Yang, Y. (2021). One pot synthesis of aryl nitriles from aromatic aldehydes in a water environment. RSC Advances, 2021.